申请人:THE GOVERNMENT OF THE UNITED STATES OF AMERICA as
represented by the SECRETARY OF THE DEPARTMENT OF
HEALTH AND HUMAN SERVICES
公开号:EP2172478A2
公开(公告)日:2010-04-07
The present invention relates generally to Activity Dependent Neurotrophic Factor III (ADNF III), also known as Activity Dependent Neuroprotective Protein (ADNP). More particularly, the present invention relates to nucleic acid sequences encoding ADNF III polypeptides; ADNF III polypeptides encoded by such nuclei acid sequences; antibodies to ADNF III polypeptides; and methods of using such ADNF III polypeptides for the treatment of neurological deficiencies and for the prevention of cell death associated with (1) gp 120, the envelope protein from HIV; (2) N-methyl-D-aspartic acid (excito-toxicity); (3) tetrodotoxin (blockage of electrical activity); and (4) β-amyloid peptide, a substance related to neuronal degeneration in Alzheimer's disease.
本发明一般涉及活动依赖性神经营养因子 III(ADNF III),也称为活动依赖性神经保护蛋白(ADNP)。更具体地说,本发明涉及编码 ADNF III 多肽的核酸序列;由此类核酸序列编码的 ADNF III 多肽;ADNF III 多肽的抗体;以及使用这种 ADNF III 多肽治疗神经系统缺陷和预防细胞死亡的方法,这些神经系统缺陷和细胞死亡与以下物质有关:(1)gp 120,HIV 的包膜蛋白;(2)N-甲基-D-天冬氨酸(兴奋毒性);(3)河豚毒素(电活动阻断);以及(4)β-淀粉样肽,一种与阿尔茨海默氏症中神经元变性有关的物质。